Purpose To provide comprehensive data on the diagnostic and prognostic value of [18F]-
FDG PET (PET) in anal canal cancer patients. Methods This study was designed following …

Positron emission tomography (PET) in the era of personalized medicine has a unique role
in the management of oncological patients and offers several advantages over standard …

Anal squamous cell carcinoma (SCC) is a relatively rare cancer comprising less than 2.5%
of all gastrointestinal malignancies. The standard treatment for anal SCC is primary …

The incidence and mortality of squamous cell carcinoma of the anus (SCCA) is on the rise,
which highlights the unmet need for advances in treatment options. The landscape of …

The role and method of image-based staging of anal cancer has evolved with the rapid
development of newer imaging modalities and the need to address the rising incidence of …

Purpose To investigate the differences in baseline staging of anal squamous cell carcinoma
based on CT, MRI, and PET/CT, and the resultant impact on the radiation plan. Methods This …

Objectives Pre-treatment staging of anal squamous cell carcinoma (ASCC) includes pelvic
MRI and [18F]-fluorodeoxyglucose positron emission tomography with computed …

In den letzten Jahren hat sich die Verfügbarkeit der PET bzw. PET/CT und PET/MR soweit
etabliert, dass sie nahezu jedem onkologischen Patienten zur Verfügung steht. Für …

Molecular imaging and therapy play an increasingly important role in the field of “precision
medicine” as an emergent prospect for management of the cancerous disease. In this novel …

Objectives: This study aimed to predict the RAS mutation by using imaging techniques and
routine clinical or laboratory findings without tissue samples. Methods: The study was …